Dr. Kang Tao
- Vice president, Medium Biomedicine (Suzhou) Co., Ltd.
Dr Kang, vice president of The Medium Biomedicine (Suzhou) Co., Ltd., Ph.D. graduated from Wuhan Institute of Virology, Chinese Academy of Sciences, Master’s degree from University of Texas Health Science Center at San Antonio. He formerly served as a Visiting researcher at the University of Texas, Guest professor of Southern Medical University at Guangzhou, Director of translational development at Ractigen Therapeutics Co., Ltd., Director of technology and strategic development of Jiangsu Yaohai Biopharmaceutical Co., Ltd., Director of R&D of Guangzhou Recomgen Biotech Co., Ltd. More than 10 years of experience in biopharmaceutical development, registration and R&D management.